Speaker illustration

Doctor Monica Verdoia

ASL Biella Hospital of the Sick University of Eastern Piedmont, Biella (Italy)

Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.

Event: ESC Congress 2021 - The Digital Experience

Topic: Primary Percutaneous Coronary Intervention (PCI)

Session: Interventional Cardiology ePosters


Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: a 1-year analysis of the REDUCE trial

Event: ESC Congress 2019

Topic: Revascularisation

Session: Long term prognosis in coronary artery disease


Impact of anticoagulation strategy with bivalirudin or heparin for percutaneous coronary interventions on non-access site bleedings: a meta-analysis of randomized trials.

Event: ESC Congress 2016

Topic: PCI / stents: devices and technique

Session: Strategies to modify bleeding risk during percutaneous coronary intervention


Parathyroid hormone levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with acetylsalicylic acid and clopidogrel or ticagrelor

Event: ESC Congress 2016

Topic: Thrombosis and platelets

Session: Blood markers in acute coronary syndrome


ESC 365 is supported by

logo Novo Nordisk